日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A First-in-Human, Single- and Multiple-Dose Study of APG777, a Half-Life-Extended Anti-IL-13 Monoclonal Antibody, in Healthy Volunteers.

在健康志愿者中开展的 APG777(一种半衰期延长的抗 IL-13 单克隆抗体)的首次人体单剂量和多剂量研究。

Lim Xiu Qin, Winter Erica, Nograles Kristine, Xu Jiahong, Zhang Zhi-Qiang, Thankamony Sai, Dillinger Lukas, Dambkowski Carl L

In vitro potency and pharmacokinetics of APG777, a novel anti-IL-13 mAb.

新型抗IL-13单克隆抗体APG777的体外效力和药代动力学。

Zhu Eric, Prentice Holly, Oh Jason, Shaheen Hussam, Gandhi Namita A, Wickman Grant, Dabora Rebecca, Dambkowski Carl L, Dillinger Lukas